Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDKRB2 | P30411 | 20/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7742451 | 1.00 | BDKRB2 (0.76) | BDKRB2 | |
| SCHEMBL7748425 | 0.91 | BDKRB2 (0.76) | BDKRB2 | |
| SCHEMBL7748424 | 0.91 | BDKRB2 (0.76) | BDKRB2 | |
| SCHEMBL7748519 | 0.90 | BDKRB2 (0.81) | BDKRB2 | |
| SCHEMBL7748514 | 0.90 | BDKRB2 (0.81) | BDKRB2 | |
| Hydrochloric Acid SCHEMBL7747817 | 0.90 | BDKRB2 (0.81) | BDKRB2 | |
| Hydrochloric Acid SCHEMBL7747820 | 0.90 | BDKRB2 (0.81) | BDKRB2 | |
| SCHEMBL7749717 | 0.89 | BDKRB2 (0.81) | BDKRB2 | |
| SCHEMBL7749713 | 0.89 | BDKRB2 (0.81) | BDKRB2 | |
| SCHEMBL7748323 | 0.89 | BDKRB2 (0.79) | BDKRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0622361-B1 | Heterocyclic compounds as bradykinin antagonists | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-10-04 | — | — | EP | disclosed |
| US-6169095-B1 | FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES IN THE EYE, SUCH AS ALLERGY, INFLAMMATION AND PAIN OF THE EYE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-01-02 | — | — | US | disclosed |
| EP-0622361-A1 | Heterocyclic compounds as bradykinin antagonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-11-02 | — | — | EP | disclosed |